A detailed analysis of immune cells in Long COVID patients has revealed a previously unknown molecular signature linked to lingering symptoms. In Germany, Long COVID develops in up to about one in ten ...

COVID-19 was never just a hit-and-run infection, and the latest science shows why. Even after the active virus is gone, fragments of its genetic material and spike proteins can linger, assemble into ...

While COVID-19 has been responsible for the deaths of millions of people around the world, and continues to sicken thousands every week, some people do not get sick with COVID-19 even when they are ...

NEW YORK -- Two encouraging studies suggest that people who recovered from COVID-19 had immune responses to the virus long after antibodies faded, even up to one year later. The findings may help put ...

Moderna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response against both viruses than licensed vaccines on the market, promising findings for the mRNA company as it ...

In a recent study published in the journal Nature, a group of researchers analyzed early cellular response dynamics to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in seronegative ...

(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people ...

Nipah vs COVID-19: Unlike most viral infections, the Nipah virus doesn’t just attack organs, it hijacks the immune system itself, creating a deadly internal battle the body often cannot win.

To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver ...